isabelobrien, Author at European Medical Journal - Page 44 of 68

Spoonful of technology: Oct-Dec 2023

Dive into the top technology stories of the past few months as GOLD explores the funding landscape and the latest innovations in the health tech market

Get ready for Gen Z doctors

A new generation of doctors is making their way into the workforce, but is the pharmaceutical industry ready to change its tactics to engage these younger HCPs?

Has medical affairs reached 'strategic pillar' standing?

The value of medical affairs is not up for debate, but are companies allocating enough time and resources to make it the strategic function it can be?

VPAG: the UK's ticket to pharma superpower status?

A deal ends months of wrangling between the UK government and the ABPI, but what will it mean for the industry and the UK’s bid to become a life sciences superpower?

Haematology under the microscope

This infographic explores the vastness of the haematology market, including key industry players, drugs to watch, the global burden of haematological diseases and more.

Cardiology under the microscope

This infographic explores the ins and outs of the cardiology market, including market size, top pharmaceutical and medical device players and the regional impact of cardiovascular disease.

Should sales be a ‘dirty’ word in medical affairs?

Medical affairs and sales teams have distinctly different roles, but aren’t they just two planets orbiting the same sun?

Catching the ever elusive insight

How can medical affairs achieve efficiencies by standardising and modernising its insight gathering processes?

Staying out of hot water on social media

As the UK PMCPA publishes its first social media guidance for pharmaceutical companies, what can they do to avoid traps when it comes to posting online?

Going for gold in gynaecological cancers

The pharmaceutical industry is being urged to take action to bridge the access gap for women with gynaecological cancers, but what steps are needed to change the game?